Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 29
2014 46
2015 45
2016 53
2017 72
2018 58
2019 53
2020 44
2021 49
2022 63
2023 62
2024 18

Text availability

Article attribute

Article type

Publication date

PubMed for id: 852220

500 results

Results by year

Filters applied: . Clear all
Page 1
TP53 in MDS and AML: Biological and clinical advances.
Zhao Y, Chen W, Yu J, Pei S, Zhang Q, Shi J, Huang H, Zhao Y. Zhao Y, et al. Cancer Lett. 2024 Apr 28;588:216767. doi: 10.1016/j.canlet.2024.216767. Epub 2024 Feb 27. Cancer Lett. 2024. PMID: 38417666 Review.
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression.
Casalin I, De Stefano A, Ceneri E, Cappellini A, Finelli C, Curti A, Paolini S, Parisi S, Zannoni L, Boultwood J, McCubrey JA, Suh PG, Ramazzotti G, Fiume R, Ratti S, Manzoli L, Cocco L, Follo MY. Casalin I, et al. Adv Biol Regul. 2024 Jan;91:101014. doi: 10.1016/j.jbior.2024.101014. Epub 2024 Jan 12. Adv Biol Regul. 2024. PMID: 38242820 Free article.
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms.
Kaisrlikova M, Kundrat D, Koralkova P, Trsova I, Lenertova Z, Votavova H, Merkerova MD, Krejcik Z, Vesela J, Vostry M, Simeckova R, Markova MS, Lauermannova M, Jonasova A, Cermak J, Divoky V, Belickova M. Kaisrlikova M, et al. Int J Cancer. 2024 May 1;154(9):1652-1668. doi: 10.1002/ijc.34834. Epub 2024 Jan 5. Int J Cancer. 2024. PMID: 38180088
500 results